Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Cancer & In Silico Oncology Task Force

Cancer & In Silico Oncology Task Force

BACK

Cancer & In Silico Oncology Task Force

Mission: Accelerate, optimize and personalize cancer treatment through the development, clinical validation and clinical translation of in silico methods

Cancer is such a complex global threat that the European Commission has included it in the list of the five prioritized research missions of the Horizon Europe research and innovation programme for the years 2021-2027.

As a branch of the Avicenna Research & Technology WG, the Cancer and In Silico Oncology TF has the objective to accelerate, optimize and personalize cancer treatment through the development, clinical validation and clinical translation of in silico methods.

Goals

  • Develop clinically driven and overseen digital twins of tumour growth and tumour and organism response to cancer treatment interventions.
  • Ensure trustworthiness, explainability, robustness, stability and good quality of component interconnection for all underying mechanistic and/or AI and/or hybrid models.
  • Technically and clinically validate cancer digital twins through formal clinical studies, including clinical trials.
  • Translate cancer digital twins into clinical practice, following certification
  • Monitor and evaluate the clinical use of certified cancer digital twins and further exploit the latter for in silico clinical trials and broader clinical research.


Georgios Stamatakos

Georgios Stamatakos

Co-Chair of the Cancer & In Silico OncologyTask Force

Research Professor, National Technical University of Athens (NTUA)

READ BIO

NEWS

News ADVANCING THE VIRTUAL HUMAN TWIN ECOSYSTEM - Avicenna Alliance at VHT Net Initiative Meeting

ADVANCING THE VIRTUAL HUMAN TWIN ECOSYSTEM - Avicenna Alliance at VHT Net Initiative Meeting

On 20 October, Avicenna Alliance was represented by many members and partners, including our President and Secretary General, Thierry Marchal, at the annual VHT Net initiative meeting, organised by the VPH - The Society for In Silico Medicine at the European Commission.

News SILICA General Assembly - Strengthening collaboration on AI, synthetic data and in silico methods in healthcare

SILICA General Assembly - Strengthening collaboration on AI, synthetic data and in silico methods in healthcare

The Avicenna Alliance is pleased to support initiatives that bring stakeholders together to advance the use of artificial intelligence, synthetic data, and computational modelling and simulation in healthcare.

News Avicenna Days (AAD) 2027

Avicenna Days (AAD) 2027

Three days. One journey. From research to real-world impact.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry